Gamma-retroviral/lentiviral vectors (γRV/LV) with self-inactivating (SIN) long terminal repeats (LTRs) and internal moderate cellular promoters pose a reduced risk of insertional mutagenesis when compared with vectors with active LTRs. Yet, in a recent LV-based clinical trial for β-thalassemia, vector integration within the HMGA2 gene induced the formation of an aberrantly spliced mRNA form that appeared to cause clonal dominance. Using a method that we developed, cDNA linear amplification-mediated PCR, in combination with high-throughput sequencing, we conducted a whole transcriptome analysis of chimeric LV-cellular fusion transcripts in transduced human lymphoblastoid cells and primary hematopoietic stem/progenitor cells. We observed a surprising abundance of read-through transcription originating outside and inside the provirus and identified the vector sequences contributing to the aberrant splicing process. We found that SIN LV has a sharply reduced propensity to engage in aberrant splicing compared with that of vectors carrying active LTRs. Moreover, by recoding the identified vector splice sites, we reduced residual read-through transcription and demonstrated an effective strategy for improving vectors. Characterization of the mechanisms and genetic features underlying vector-induced aberrant splicing will enable the generation of safer vectors, with low impact on the cellular transcriptome.
Daniela Cesana, Jacopo Sgualdino, Laura Rudilosso, Stefania Merella, Luigi Naldini, Eugenio Montini
Title and authors | Publication | Year |
---|---|---|
Effects of an indole derivative on cell proliferation, transfection, and alternative splicing in production of lentiviral vectors by transient co-transfection
Mier NC, Roper DK |
PloS one | 2024 |
Mechanisms and Delivery of tRNA Therapeutics
Ward C, Beharry A, Tennakoon R, Rozik P, Wilhelm SD, Heinemann IU, O\u2019Donoghue P |
Chemical Reviews | 2024 |
Optimization of a lentivirus-mediated gene therapy targeting HIV-1 RNA to eliminate HIV-1-infected cells
Buckingham AB, Ho S, Knops-Mckim F, Ingemarsdotter CK, Lever AM |
Molecular Therapy. Nucleic Acids | 2024 |
Balancing efficacy and safety in lentiviral vector-mediated hematopoietic stem cell gene therapy
Montini E, Naldini L, Booth C, Kohn DB, Aiuti A |
Molecular Therapy | 2024 |
CRISPR-Cas9-AAV versus lentivector transduction for genome modification of X-linked severe combined immunodeficiency hematopoietic stem cells
Brault J, Liu T, Liu S, Lawson A, Choi U, Kozhushko N, Bzhilyanskaya V, Pavel-Dinu M, Meis RJ, Eckhaus MA, Burkett SS, Bosticardo M, Kleinstiver BP, Notarangelo LD, Lazzarotto CR, Tsai SQ, Wu X, Dahl GA, Porteus MH, Malech HL, De Ravin SS |
Frontiers in immunology | 2023 |
Editorial: The relevance of molecular mechanisms in HIV-1 latency and reactivation from latency
Pasternak AO, Rohr O, Van Lint C, Kula-Pacurar A |
Frontiers in Cellular and Infection Microbiology | 2023 |
Correcting inborn errors of immunity: From viral mediated gene addition to gene editing
Castiello MC, Ferrari S, Villa A |
Seminars in Immunology | 2023 |
Emerging Gene Therapy Technologies for Retinal Ganglion Cell Neuroprotection
Camacho DK, Go CC, Chaqour B, Shindler KS, Ross AG |
Journal of Neuro-Ophthalmology | 2023 |
Detection of Chimeric Cellular: HIV mRNAs Generated Through Aberrant Splicing in HIV-1 Latently Infected Resting CD4+ T Cells.
Lee MY, Khoury G, Olshansky M, Sonza S, Carter GP, McMahon J, Stinear TP, Turner SJ, Lewin SR, Purcell DFJ |
Frontiers in Cellular and Infection Microbiology | 2022 |
Lentivector cryptic splicing mediates increase in CD34+ clones expressing truncated HMGA2 in human X-linked severe combined immunodeficiency
De Ravin SS, Liu S, Sweeney CL, Brault J, Whiting-Theobald N, Ma M, Liu T, Choi U, Lee J, O\u2019Brien SA, Quackenbush P, Estwick T, Karra A, Docking E, Kwatemaa N, Guo S, Su L, Sun Z, Zhou S, Puck J, Cowan MJ, Notarangelo LD, Kang E, Malech HL, Wu X |
Nature Communications | 2022 |
Evaluating the state of the science for adeno-associated virus integration: An integrated perspective
Sabatino DE, Bushman FD, Chandler RJ, Crystal RG, Davidson BL, Dolmetsch R, Eggan KC, Gao G, Gil-Farina I, Kay MA, McCarty DM, Montini E, Ndu A, Yuan J |
Molecular Therapy | 2022 |
Aberrant splicing events caused by insertion of genes of interest into expression vectors
Cheng Y, Kang XZ, Chan P, Ye ZW, Chan CP, Jin DY |
International journal of biological sciences | 2022 |
Determinants of Retroviral Integration and Implications for Gene Therapeutic MLV—Based Vectors and for a Cure for HIV-1 Infection
Pellaers E, Bhat A, Christ F, Debyser Z |
Viruses | 2022 |
T-Helper Cells: Methods and Protocols
F Annunziato, L Maggi, A Mazzoni |
2021 | |
Viral vector platforms within the gene therapy landscape
JT Bulcha, Y Wang, H Ma, PW Tai, G Gao |
Signal Transduction and Targeted Therapy | 2021 |
HIV-based lentiviral vectors: Origin and sequence differences
NM Johnson, AF Alvarado, TN Moffatt, JM Edavettal, TA Swaminathan, SE Braun |
Molecular Therapy — Methods & Clinical Development | 2021 |
Designing Lentiviral Vectors for Gene Therapy of Genetic Diseases
V Poletti, F Mavilio |
Viruses | 2021 |
The Splice of Life: Does RNA Processing Have a Role in HIV-1 Persistence?
AO Pasternak, B Berkhout |
Viruses | 2021 |
Overexpression of lncRNAs with endogenous lengths and functions using a lncRNA delivery system based on transposon
Y Zhang, YX Huang, X Jin, J Chen, L Peng, DL Wang, Y Li, XY Yao, JY Liao, JH He, KS Hu, D Lu, Y Guo, D Yin |
Journal of nanobiotechnology | 2021 |
AAV-BASED GENE THERAPY FOR LIFE-LONG CORRECTION OF GENETIC DISEASE
C Brommel, A Cooney, PL Sinn |
Human Gene Therapy | 2020 |
Aberrant Clonal Hematopoiesis following Lentiviral Vector Transduction of HSPCs in a Rhesus Macaque
DA Espinoza, X Fan, D Yang, SF Cordes, LL Truitt, KR Calvo, IM Yabe, S Demirci, KJ Hope, SG Hong, A Krouse, M Metzger, A Bonifacino, R Lu, N Uchida, JF Tisdale, X Wu, SS DeRavin, HL Malech, RE Donahue, C Wu, CE Dunbar |
Molecular Therapy | 2019 |
Viral modulation of cellular RNA alternative splicing: A new key player in virus–host interactions?
S Boudreault, P Roy, G Lemay, M Bisaillon |
Wiley interdisciplinary reviews. RNA | 2019 |
The role of integration and clonal expansion in HIV infection: live long and prosper
EM Anderson, F Maldarelli |
Retrovirology | 2018 |
Preclinical Development of a Lentiviral Vector for Gene Therapy of X-Linked Severe Combined Immunodeficiency
V Poletti, S Charrier, G Corre, B Gjata, A Vignaud, F Zhang, M Rothe, A Schambach, HB Gaspar, AJ Thrasher, F Mavilio |
Molecular Therapy — Methods & Clinical Development | 2018 |
Replication-incompetent gammaretroviral and lentiviral vector-based insertional mutagenesis screens identify prostate cancer progression genes
VM Bii, CP Collins, JD Hocum, GD Trobridge |
Oncotarget | 2018 |
Multiple Integrated Non-clinical Studies Predict the Safety of Lentivirus-Mediated Gene Therapy for β-Thalassemia
MR Lidonnici, Y Paleari, F Tiboni, G Mandelli, C Rossi, M Vezzoli, A Aprile, CW Lederer, A Ambrosi, F Chanut, F Sanvito, A Calabria, V Poletti, F Mavilio, E Montini, L Naldini, P Cristofori, G Ferrari |
Molecular Therapy — Methods & Clinical Development | 2018 |
Ex Vivo Selection of Transduced Hematopoietic Stem Cells for Gene Therapy of β-Hemoglobinopathies
K Bhukhai, E de Dreuzy, M Giorgi, C Colomb, O Negre, M Denaro, B Gillet-Legrand, J Cheuzeville, A Paulard, H Trebeden-Negre, S Borwornpinyo, K Sii-Felice, L Maouche, JD Down, P Leboulch, E Payen |
Molecular Therapy | 2018 |
Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease
V Poletti, F Urbinati, S Charrier, G Corre, RP Hollis, BC Fernandez, S Martin, M Rothe, A Schambach, DB Kohn, F Mavilio |
Molecular Therapy — Methods & Clinical Development | 2018 |
An RNA-targeted therapy for dystrophic epidermolysis bullosa
P Peking, U Koller, B Duarte, R Murillas, S Wolf, T Maetzig, M Rothe, T Kocher, M García, G Brachtl, A Schambach, F Larcher, J Reichelt, JW Bauer, EM Murauer |
Nucleic Acids Research | 2017 |
Engineering of PEDF-Expressing Primary Pigment Epithelial Cells by the SB Transposon System Delivered by pFAR4 Plasmids
G Thumann, N Harmening, C Prat-Souteyrand, C Marie, M Pastor, A Sebe, C Miskey, LD Hurst, S Diarra, M Kropp, P Walter, D Scherman, Z Ivics, Z Izsvák, S Johnen |
Molecular Therapy - Nucleic Acids | 2017 |
HIV-1-mediated insertional activation of STAT5B and BACH2 trigger viral reservoir in T regulatory cells
D Cesana, FR de Sio, L Rudilosso, P Gallina, A Calabria, S Beretta, I Merelli, E Bruzzesi, L Passerini, S Nozza, E Vicenzi, G Poli, S Gregori, G Tambussi, E Montini |
Nature Communications | 2017 |
Targeting Splicing in the Treatment of Human Disease
M Suñé-Pou, S Prieto-Sánchez, S Boyero-Corral, C Moreno-Castro, YE Yousfi, J Suñé-Negre, C Hernández-Munain, C Suñé |
Genes & development | 2017 |
Pervasive supply of therapeutic lysosomal enzymes in the CNS of normal and Krabbe‐affected non‐human primates by intracerebral lentiviral gene therapy
V Meneghini, A Lattanzi, L Tiradani, G Bravo, F Morena, F Sanvito, A Calabria, J Bringas, JM FisherPerkins, JP Dufour, KC Baker, C Doglioni, E Montini, BA Bunnell, K Bankiewicz, S Martino, L Naldini, A Gritti |
EMBO Molecular Medicine | 2016 |
Rapid and Efficient Stable Gene Transfer to Mesenchymal Stromal Cells Using a Modified Foamy Virus Vector
NP Sweeney, C Regan, J Liu, A Galleu, F Dazzi, D Lindemann, CA Rupar, MO McClure |
Molecular Therapy | 2016 |
Towards a Safer, More Randomized Lentiviral Vector Integration Profile Exploring Artificial LEDGF Chimeras
LS Vranckx, J Demeulemeester, Z Debyser, R Gijsbers, Y Ikeda |
PloS one | 2016 |
A comparison of foamy and lentiviral vector genotoxicity in SCID-repopulating cells shows foamy vectors are less prone to clonal dominance
EM Everson, ME Olzsko, DJ Leap, JD Hocum, GD Trobridge |
Molecular Therapy — Methods & Clinical Development | 2016 |
Identifying Cancer Driver Genes Using Replication-Incompetent Retroviral Vectors
V Bii, G Trobridge |
Cancers | 2016 |
Targeted approaches to induce immune tolerance for Pompe disease therapy
PA Doerfler, S Nayak, M Corti, L Morel, RW Herzog, BJ Byrne |
Molecular Therapy — Methods & Clinical Development | 2016 |
Generation of a stable packaging cell line producing high-titer PPT-deleted integration-deficient lentiviral vectors
P Hu, Y Li, MS Sands, T McCown, T Kafri |
Molecular Therapy — Methods & Clinical Development | 2015 |
Gene activity in primary T cells infected with HIV89.6: intron retention and induction of genomic repeats
S Sherrill-Mix, KE Ocwieja, FD Bushman |
Retrovirology | 2015 |
Gene therapy: progress and predictions
M Collins, A Thrasher |
Proceedings of the Royal Society B: Biological Sciences | 2015 |
A minimal ubiquitous chromatin opening element (UCOE) effectively prevents silencing of juxtaposed heterologous promoters by epigenetic remodeling in multipotent and pluripotent stem cells
U Muller-Kuller, M Ackermann, S Kolodziej, C Brendel, J Fritsch, N Lachmann, H Kunkel, J Lausen, A Schambach, T Moritz, M Grez |
Nucleic Acids Research | 2015 |
Uncovering and dissecting the genotoxicity of self-inactivating lentiviral vectors in vivo
D Cesana, M Ranzani, M Volpin, C Bartholomae, C Duros, A Artus, S Merella, F Benedicenti, LS Sergi, F Sanvito, C Brombin, A Nonis, CD Serio, C Doglioni, C Kalle, M Schmidt, O Cohen-Haguenauer, L Naldini, E Montini |
Molecular Therapy | 2014 |
Concise Review: Lessons Learned From Clinical Trials of Gene Therapy in Monogenic Immunodeficiency Diseases
DA Williams, AJ Thrasher |
Stem Cells Translational Medicine | 2014 |
Integration Site and Clonal Expansion in Human Chronic Retroviral Infection and Gene Therapy
H Niederer, C Bangham |
Viruses | 2014 |
Genomic Analysis of Sleeping Beauty Transposon Integration in Human Somatic Cells
G Turchiano, MC Latella, A Gogol-Döring, C Cattoglio, F Mavilio, Z Izsvák, Z Ivics, A Recchia, SD Fugmann |
PloS one | 2014 |
Efficient transduction of LEDGF/p75 mutant cells by complementary gain-of-function HIV-1 integrase mutant viruses
H Wang, MC Shun, X Li, FD Nunzio, S Hare, P Cherepanov, A Engelman |
Molecular Therapy — Methods & Clinical Development | 2014 |
Novel principles of gamma-retroviral insertional transcription activation in murine leukemia virus-induced end-stage tumors
M Sokol, M Wabl, IR Ruiz, FS Pedersen |
Retrovirology | 2014 |
Genome-Wide Analysis of Alpharetroviral Integration in Human Hematopoietic Stem/Progenitor Cells
A Moiani, JD Suerth, F Gandolfi, E Rizzi, M Severgnini, GD Bellis, A Schambach, F Mavilio |
Genes & development | 2014 |
Lentiviral Vectors for Cancer Immunotherapy and Clinical Applications
T Liechtenstein, N Perez-Janices, D Escors |
Cancers | 2013 |
Differentiated neuroprogenitor cells incubated with human or canine adenovirus, or lentiviral vectors have distinct transcriptome profiles
S Piersanti, L Astrologo, V Licursi, R Costa, E Roncaglia, A Gennetier, S Ibanes, M Chillon, R Negri, E Tagliafico, EJ Kremer, I Saggio |
PloS one | 2013 |
Evaluating risks of insertional mutagenesis by DNA transposons in gene therapy
PB Hackett, DA Largaespada, KC Switzer, LJ Cooper |
Translational Research | 2013 |
No Impact of Lentiviral Transduction on Hematopoietic Stem/Progenitor Cell Telomere Length or Gene Expression in the Rhesus Macaque Model
SE Sellers, B Dumitriu, MJ Morgan, WM Hughes, CO Wu, N Raghavarchari, Y Yang, N Uchida, JF Tisdale, DS An, IS Chen, P Hematti, RE Donahue, A LaRochelle, NS Young, RT Calado, CE Dunbar |
Molecular Therapy | 2013 |
Biosafety features of lentiviral vectors
A Schambach, D Zychlinski, B Ehrnstrom, C Baum |
Human Gene Therapy | 2013 |
Foamy Virus Vectors for HIV Gene Therapy
M Olszko, G Trobridge |
Viruses | 2013 |
Cancer gene discovery: exploiting insertional mutagenesis
M Ranzani, S Annunziato, DJ Adams, E Montini |
Molecular cancer research : MCR | 2013 |
Deletion of the LTR enhancer/promoter has no impact on the integration profile of MLV vectors in human hematopoietic progenitors
A Moiani, A Miccio, E Rizzi, M Severgnini, D Pellin, JD Suerth, C Baum, GD Bellis, F Mavilio |
PloS one | 2013 |
Transduction of Fetal Mice With a Feline Lentiviral Vector Induces Liver Tumors Which Exhibit an E2F Activation Signature
R Condiotti, D Goldenberg, H Giladi, T Schnitzer-Perlman, SN Waddington, SM Buckley, D Heim, W Cheung, M Themis, C Coutelle, A Simerzin, E Osejindu, H Wege, M Themis, E Galun |
Molecular Therapy | 2013 |
Human miR223 promoter as a novel myelo-specific promoter for chronic granulomatous disease gene therapy
C Brendel, W Hänseler, V Wohlgensinger, M Bianchi, S Tokmak, L Chen-Wichmann, E Kuzmenko, N Cesarovic, F Nicholls, J Reichenbach, R Seger, M Grez, U Siler |
Human Gene Therapy Methods | 2013 |
Retroviral and Lentiviral Vectors for the Induction of Immunological Tolerance
I Dufait, T Liechtenstein, A Lanna, C Bricogne, R Laranga, A Padella, K Breckpot, D Escors |
Scientifica | 2012 |
Development of Gene Therapy for Thalassemia
AW Nienhuis, DA Persons |
Cold Spring Harbor Perspectives in Medicine | 2012 |
Gene therapy: too much splice can spoil the dish
D Trono |
Journal of Clinical Investigation | 2012 |
Alpharetroviral Vector-mediated Gene Therapy for X-CGD: Functional Correction and Lack of Aberrant Splicing
KB Kaufmann, C Brendel, JD Suerth, U Mueller-Kuller, L Chen-Wichmann, J Schwäble, S Pahujani, H Kunkel, A Schambach, C Baum, M Grez |
Molecular Therapy | 2012 |